ニフェディピンの臨床試験

Same author

Urocortin 2 - a protective effect in hypertension?

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023

Same author

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

International journal of cardiology·2021

Same author

More SPRINT controversy.

Journal of internal medicine·2017

Same author

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Hipertension y riesgo vascular·2015

Same author

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Journal of internal medicine·2009

Same author

Beta-blockers as fourth-line therapy for hypertension: stay the course.

International journal of clinical practice·2009

Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026

Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026

Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026

Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026

Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026

Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026

関連する実験動画

ニフェディピンの臨床試験

関連する概念動画

Urocortin 2 - a protective effect in hypertension?

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

More SPRINT controversy.

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Beta-blockers as fourth-line therapy for hypertension: stay the course.

Eugene Braunwald, MD, 1929-2026.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

関連する実験動画

ニフェディピンの臨床試験

関連する概念動画

関連記事

Urocortin 2 - a protective effect in hypertension?

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

More SPRINT controversy.

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Beta-blockers as fourth-line therapy for hypertension: stay the course.

Eugene Braunwald, MD, 1929-2026.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.